NUVATION BIO INC (NUVB) Stock Analyst Earnings Estimates
NYSE:NUVB - New York Stock Exchange, Inc. - US67080N1019 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A 374.06% | N/A 764.11% | N/A 73.72% | N/A 41.74% | N/A 75.20% | N/A 39.06% | N/A 28.85% | N/A 24.40% | |||||||
| EBITDA YoY % growth | N/A | -32.09M | -43.45M -35.40% | -93.14M -114.36% | -112.13M -20.39% | -99.6M 11.17% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -740K | -32.1M -4,237.84% | -43.55M -35.67% | -93.32M -114.28% | -112.33M -20.37% | -99.822M 11.14% | N/A -500.21% | N/A 62.87% | N/A 3.40% | N/A 17.71% | N/A 23.96% | N/A 80.20% | N/A 314.44% | N/A 200.26% | N/A 72.72% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -0.44 -180.11% | -0.48 -9.09% | -0.34 29.17% | N/A -547.40% | N/A 71.36% | N/A 18.28% | N/A 50.50% | N/A 120.00% | N/A -1,120.00% | N/A -3.92% | N/A | N/A |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.14 -134.60% | -0.15 -108.85% | -0.15 -2.00% | -0.17 -13.34% | -0.18 -25.60% |
| Revenue Q2Q % growth | -100.00% | 1.546M 112.65% | 4.792M | ||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -49.683M -138.51% | -55.427M -174.40% | -59.372M -31.02% | -61.003M -26.82% | -62.747M -26.29% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.15 -66.67% | -0.13 | -0.02 | -13.12% |
| Q2 2024 Q2Q % growth | -0.15 -66.67% | -0.06 | -0.09 | -151.38% |
| Q1 2024 Q2Q % growth | -0.07 30.00% | -0.10 | 0.03 | 28.36% |
| Q4 2023 Q2Q % growth | -0.06 40.00% | -0.11 | 0.05 | 43.89% |
| Q3 2023 Q2Q % growth | -0.09 25.00% | -0.11 | 0.02 | 19.54% |
| Q2 2023 Q2Q % growth | -0.09 43.75% | -0.11 | 0.02 | 21.10% |
| Q1 2023 Q2Q % growth | -0.10 | -0.10 | 0.00 | 1.96% |
| Q4 2022 Q2Q % growth | -0.10 16.67% | -0.12 | 0.02 | 14.75% |
| Q3 2022 Q2Q % growth | -0.12 -9.09% | -0.14 | 0.02 | 15.97% |
| Q2 2022 Q2Q % growth | -0.16 -77.78% | -0.14 | -0.02 | -18.07% |
| Q1 2022 Q2Q % growth | -0.10 16.67% | -0.15 | 0.05 | 31.92% |
| Q4 2021 Q2Q % growth | -0.12 -152.08% | -0.12 | 0.00 | 0.58% |
| Q3 2021 Q2Q % growth | -0.11 | -0.11 | 0.00 | -1.74% |
| Q2 2021 Q2Q % growth | -0.09 | -0.10 | 0.01 | 9.96% |
| Q1 2021 Q2Q % growth | -0.12 | -0.07 | -0.05 | -68.07% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -0.36% | -0.36% | 0.55% | -1.79% |
| Revenue | N/A | N/A | 0% | 15.5% |